Heal the world

Transforming Global Health with Science & Compassion

Transforming Global Health with Science & Compassion

MISSION

Healing without harm

At Quercis Pharma, we believe true innovation is measured not only by drug discovery and development, but by the product of our work being able to reach patients everywhere. Science can transform lives if it is accessible, affordable, and equitable.

We are committed to

Making lifesaving medicines a right, not a privilege

Delivering treatments sustainably and responsibly across all communities

Putting patients before profits in everything we do

PHILOSOPHY

Our Credo

Be honest with ourselves, our researchers, our collaborators, regulators and patients, always making transparency a key component of our drug development programs.

We are responsible first to the patients who use our products, and then to make sure our drugs work to redefine what is possible in human health.

We recognize the need to increase access to and lower the cost of medicines to improve quality of life for all. We are committed to providing equitable access to our medicines. We are focused on managing the cost of our products to those less fortunate, making them available to even those in the most dire economic circumstances.

Profit is not an ugly word. We must be profitable to achieve our goals and live by our credo. We will not profit unfairly from those less fortunate.

We are passionate about including people of all backgrounds in our mission. We support each persons pursuit of equality, peace, freedom and fairness regardless of their nationality, color, creed, religion or gender identity.

We espouse togetherness and shared work in finding solutions for global problems such as the fight for affordable healthcare and education for all.

We encourage respect, tolerance, peace and freedom of choice. We stand against racism, radicalism and all who needlessly harm others.

We are ready to assume a leadership role in transforming global health and each of us at Quercis hopes to leave the world a better place than when we arrived in it.

TEAM

A world-class team for a global mission

Quercis brings together leaders in oncology, hematology, immunology, and neurology, supported by a world-class Scientific Advisory Board

Senior Leadership

Thomas Lines D.Sc (h.c.)

Chairman and CEO

Stefan Wohlfeil, MD

CMO

Harry Welten

CFO

Richard O'Neil JD

COO

Daniel Drexler, MD

CEO, Quercis USA

Thomas Lines D.Sc (h.c.)

Chairman and CEO

Stefan Wohlfeil, MD

CMO

Harry Welten

CFO

Richard O'Neil JD

COO

Daniel Drexler, MD

CEO, Quercis USA

Thomas Lines D.Sc (h.c.)

Chairman and CEO

Stefan Wohlfeil, MD

CMO

Harry Welten

CFO

Richard O'Neil JD

COO

Daniel Drexler, MD

CEO, Quercis USA

Key Personnel

Natalia Seipel Nikolic, JD

Global Manager: Corporate and Business Development

Yves Grumser MD

Clinical Trial Supervisor

Natalia Seipel Nikolic, JD

Global Manager: Corporate and Business Development

Yves Grumser MD

Clinical Trial Supervisor

Natalia Seipel Nikolic, JD

Global Manager: Corporate and Business Development

Yves Grumser MD

Clinical Trial Supervisor

Board of Directors

Thomas Lines D.Sc (h.c.)

Chairman and CEO

Gerhard Ries, Ph.D

Board Member

Thomas Lines D.Sc (h.c.)

Chairman and CEO

Gerhard Ries, Ph.D

Board Member

Thomas Lines D.Sc (h.c.)

Chairman and CEO

Gerhard Ries, Ph.D

Board Member

Scientific Advisory Board

Our Strategic Advisory Board includes global leaders in oncology, hematology, immunology, and neurology

Prof. Dr. Jean-Pierre Kinet

Immunologist and Professor Emeritus at Harvard Medical School

Prof. Dr. Jean Pierre Bizzari

Chairman Scientific Advisory Board, Chairman of EORTC New Drug Advisory Committee, Former CMO Celgene

Prof. Dr. Manuel Hildalgo

Chief of the Division of Hematology and Medical Oncology at the Weill Department of Medicine, Cornell University

Prof. Dr. Louis Barbeito

Former Head Laboratory of Neurodegeneration at Pasteur Institute in Uruguay

Prof. Dr. Simone Schürle-Finke

Head of Responsive Biomedical System Lab at ETH, Zurich

Prof. Dr. Jean-Pierre Kinet

Immunologist and Professor Emeritus at Harvard Medical School

Prof. Dr. Jean Pierre Bizzari

Chairman Scientific Advisory Board, Chairman of EORTC New Drug Advisory Committee, Former CMO Celgene

Prof. Dr. Manuel Hildalgo

Chief of the Division of Hematology and Medical Oncology at the Weill Department of Medicine, Cornell University

Prof. Dr. Louis Barbeito

Former Head Laboratory of Neurodegeneration at Pasteur Institute in Uruguay

Prof. Dr. Simone Schürle-Finke

Head of Responsive Biomedical System Lab at ETH, Zurich

Prof. Dr. Jean-Pierre Kinet

Immunologist and Professor Emeritus at Harvard Medical School

Prof. Dr. Jean Pierre Bizzari

Chairman Scientific Advisory Board, Chairman of EORTC New Drug Advisory Committee, Former CMO Celgene

Prof. Dr. Manuel Hildalgo

Chief of the Division of Hematology and Medical Oncology at the Weill Department of Medicine, Cornell University

Prof. Dr. Louis Barbeito

Former Head Laboratory of Neurodegeneration at Pasteur Institute in Uruguay

Prof. Dr. Simone Schürle-Finke

Head of Responsive Biomedical System Lab at ETH, Zurich

OUR PARTNERS

Quercis partners with leading academic institutions, regulators, patient organizations, and industry leaders to accelerate the development of accessible medicines worldwide.

CONTACT

For questions regarding our investigational products, pipeline, or partnership opportunities, please reach out

Heal the world

KEY PUBLICATIONS

© 2025 Quercis Pharma. All rights reserved.

Designed by 12y.design

Heal the world

KEY PUBLICATIONS

© 2025 Quercis Pharma. All rights reserved.

Designed by 12y.design

Heal the world

KEY PUBLICATIONS

© 2025 Quercis Pharma. All rights reserved.

Designed by 12y.design